10 doctors on FDA panel for Abbott heart device had financial ties to the company.

10 doctors on FDA panel for Abbott heart device had financial ties to the company, totaling about $650,000 in payments and research funding, as reported by a federal database. Despite these connections, the FDA advisory committee voted almost unanimously that the benefits of the device outweigh its risks, leading to the approval of Abbott's TriClip heart device. This raises questions about transparency and the influence of medical industry money at the FDA.

April 06, 2024
3 Articles

Further Reading